5Newby JC, Hern RPA. Leek RD,et al. Immunohistochemical assay for EGFR on paraffinembedded sections: validation against ligand- binding assay and clinical relecance in breast cancer. Br J Can,1995,71:1237. 被引量：1
6Fitzpatrick SL,Brightwell J, Wittliff JL, et al. Epidermal growth factor binding by hreas tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Can Res, 1984, 44:3448. 被引量：1
7Hainsworth PJ, Henderson MA,Stillwell RG, et al. Comprision of EGFR,C-erbB2 product Immunohistochemistry as prognostic markers in breast cancer. Eur J Surg Oncol ,1991,17:9. 被引量：1
8Bolufer p, Miralles F. Rodriguez A. et al. EGFR in human breast:correlation with cytosolic and nuclear ER and with biological and histological tumor characteristics.Eur J Cancer,1990,26:283. 被引量：1
9Iwaya K,Tsuda H,Hiraide H,et al. Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Can Res,1991,82:835. 被引量：1
10Lewis S, Locker A ,Todd JH, et al. Expression of EGFR in breast cancer. J Clin Pathol ,1990, 43:385. 被引量：1
